Cargando…
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565379/ https://www.ncbi.nlm.nih.gov/pubmed/37525513 http://dx.doi.org/10.1002/cac2.12474 |
| _version_ | 1785118682411696128 |
|---|---|
| author | Wang, Zhenzhen Lu, Yang Liu, Yu Mou, Junli Liu, Xiaoyu Chen, Manling Wang, Ying Xu, Yingxi Rao, Qing Xing, Haiyan Tang, Kejing Tian, Zheng Wang, Bing Qi, Wei Wang, Min Qiu, Shaowei Xiong, Dongsheng Wang, Jianxiang |
| author_facet | Wang, Zhenzhen Lu, Yang Liu, Yu Mou, Junli Liu, Xiaoyu Chen, Manling Wang, Ying Xu, Yingxi Rao, Qing Xing, Haiyan Tang, Kejing Tian, Zheng Wang, Bing Qi, Wei Wang, Min Qiu, Shaowei Xiong, Dongsheng Wang, Jianxiang |
| author_sort | Wang, Zhenzhen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10565379 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105653792023-10-12 Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity Wang, Zhenzhen Lu, Yang Liu, Yu Mou, Junli Liu, Xiaoyu Chen, Manling Wang, Ying Xu, Yingxi Rao, Qing Xing, Haiyan Tang, Kejing Tian, Zheng Wang, Bing Qi, Wei Wang, Min Qiu, Shaowei Xiong, Dongsheng Wang, Jianxiang Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2023-07-31 /pmc/articles/PMC10565379/ /pubmed/37525513 http://dx.doi.org/10.1002/cac2.12474 Text en © 2023 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Wang, Zhenzhen Lu, Yang Liu, Yu Mou, Junli Liu, Xiaoyu Chen, Manling Wang, Ying Xu, Yingxi Rao, Qing Xing, Haiyan Tang, Kejing Tian, Zheng Wang, Bing Qi, Wei Wang, Min Qiu, Shaowei Xiong, Dongsheng Wang, Jianxiang Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity |
| title | Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity |
| title_full | Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity |
| title_fullStr | Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity |
| title_full_unstemmed | Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity |
| title_short | Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity |
| title_sort | novel cd123×cd33 bicistronic chimeric antigen receptor (car)‐t therapy has potential to reduce escape from single‐target car‐t with no more hematotoxicity |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565379/ https://www.ncbi.nlm.nih.gov/pubmed/37525513 http://dx.doi.org/10.1002/cac2.12474 |
| work_keys_str_mv | AT wangzhenzhen novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT luyang novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT liuyu novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT moujunli novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT liuxiaoyu novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT chenmanling novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT wangying novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT xuyingxi novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT raoqing novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT xinghaiyan novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT tangkejing novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT tianzheng novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT wangbing novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT qiwei novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT wangmin novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT qiushaowei novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT xiongdongsheng novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity AT wangjianxiang novelcd123cd33bicistronicchimericantigenreceptorcarttherapyhaspotentialtoreduceescapefromsingletargetcartwithnomorehematotoxicity |